Reliance Global Group, Inc. (EZRA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated February 19, 2026, reports on the consummation of a transaction previously announced on February 5, 2026. Reliance Global Group, Inc. (the "Company") entered into a Share Purchase Agreement with Enquantum Ltd., an Israeli company, to acquire an equity interest in Enquantum. The closing of the initial transaction occurred on February 23, 2026.
Key Financial Metrics and Transaction Details
- Initial Acquisition: The Company acquired approximately 8% of Enquantum's issued and outstanding share capital on a fully diluted basis.
- Consideration: The closing included the conversion of a previously issued secured bridge note in the principal amount of $166,000 into Enquantum ordinary shares and an additional cash investment pursuant to the first milestone tranche.
- Future Investment Structure: The agreement provides for additional milestone-based tranche investments designed to increase the Company's ownership to an aggregate of 51% of Enquantum's share capital.
- Top-Up Shares: The Company agreed to issue shares of its own common stock with an aggregate value of $125,000 to Enquantum in connection with a final control top-up intended to increase ownership from 48% to 51%. No Top-Up Shares have been issued as of the filing date.
- Financial Statements: This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics for the Company or Enquantum.
Material Changes and Amendments
On February 19, 2026, the Company and Enquantum entered into Amendment No. 1 to the Share Purchase Agreement. This amendment grants the Company the right, in its sole and absolute discretion, to accelerate the funding of any one or more milestone tranches regardless of whether the applicable milestone has been satisfied. Upon receipt of written notice, Enquantum is obligated to cooperate to consummate the issuance of shares on the designated closing date. The exercise of this acceleration right waives the milestone requirement for that specific tranche but does not waive other representations or warranties.
Management Commentary, Governance, and Risks
- Board Appointment: Ezra Beyman, the Company's Chairman and CEO, was appointed to the board of directors of Enquantum effective February 23, 2026, pursuant to governance provisions in the Share Purchase Agreement.
- Related Party Transactions: The filing states there are no related party transactions between Mr. Beyman and Enquantum requiring disclosure under Item 404(a) of Regulation S-K.
- Regulatory Status: The issuance of Enquantum shares to the Company was made in a transaction not involving a public offering, relying on Regulation S and/or Section 4(a)(2) of the Securities Act. Future Top-Up Shares will rely on Section 4(a)(2) and/or Regulation D exemptions.
- Contingencies: Future funding tranches are subject to the satisfaction (or waiver) of specified operational and commercialization milestones.
Key Facts for Investor Verification
- Verify the specific operational and commercialization milestones required to trigger future funding tranches to reach the 51% ownership target.
- Confirm the exact amount of the "additional cash investment" made during the first milestone tranche, as the filing only specifies the $166,000 bridge note conversion.
- Monitor the Company's use of the acceleration right under Amendment No. 1 to determine the timing of future capital commitments.
- Review the full text of the Share Purchase Agreement (Exhibit 10.1) and Amendment No. 1 (Exhibit 10.2) for detailed representations, warranties, and covenants.
- Track the issuance of the $125,000 Top-Up Shares, which depends on the Company's common stock price and the satisfaction of control top-up conditions.